Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00652) | |||||
---|---|---|---|---|---|
Name |
Tapentadol
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Tapentadol; 175591-23-8; Nucynta; Palexia; 3-((2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl)phenol; UNII-H8A007M585; CG5503; phenol, 3-[(1r,2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-; BN 200 (BASE); CG5503 (BASE); BN-200; H8A007M585; CG-5503; 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol; (R,R)-Tapentadol; Tapentadol [USAN:INN]; 3-((1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl)phenol; Phenol, 3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)-; BN 200; CG 5503; 3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol; Tapentadol (USAN/INN); cc-664; SCHEMBL116924; Phenol,3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-; GTPL7477; DEA No. 9780; CHEMBL1201776; CG5503 IR; HSDB 8309; ZINC20783; DTXSID30170003; CHEBI:135935; CS-M0020; 4084AH; BDBM50386381; AKOS015951190; ACN-050883; BCP9000118; DB06204; QC-1146; SB17333; FT-0699883; B-1798; D06007; AR-270/43507984; Q414463; 3-[(2R,3R)-1-dimethylamino-2-methylpentan-3-yl]phenol; (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Neuropathic pain | ICD-11: 8E43 | [1] | ||
PubChem CID | |||||
Formula |
C14H23NO
|
||||
Canonical SMILES |
CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C
|
||||
InChI |
1S/C14H23NO/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12/h6-9,11,14,16H,5,10H2,1-4H3/t11-,14+/m0/s1
|
||||
InChIKey |
KWTWDQCKEHXFFR-SMDDNHRTSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=9838022"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 221.34 | Topological Polar Surface Area | 23.5 | |
XlogP | 3.5 | Complexity | 193 | ||
Heavy Atom Count | 16 | Rotatable Bond Count | 5 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Tapentadol 150 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polyvinyl alcohol; Aluminum oxide; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Janssen Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Aluminum oxide; Hypromellose, unspecified; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Depo NF Sub | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Tapentadol 100 mg tablet | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polyvinyl alcohol; Aluminum oxide; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Janssen Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Aluminum oxide; Hypromellose, unspecified; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Depo NF Sub; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyvinyl alcohol; Povidone; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyvinyl alcohol; Povidone; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycols
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyvinyl alcohol; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Depo NF Sub | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Tapentadol 200 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polyvinyl alcohol; Aluminum oxide; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Janssen Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Aluminum oxide; Hypromellose, unspecified; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Depo NF Sub | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Tapentadol 250 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polyvinyl alcohol; Aluminum oxide; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Janssen Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Aluminum oxide; Hypromellose, unspecified; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Depo NF Sub | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Tapentadol 50 mg tablet | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polyvinyl alcohol; Hypromelloses; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Janssen Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Hypromellose, unspecified; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Depo NF Sub; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Ferrosoferric oxide; Talc; Titanium dioxide; Polyvinyl alcohol; Hypromelloses; Polyethylene glycols; Polyethylene glycols; Shellac
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyvinyl alcohol; Povidone; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Depo NF Sub | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Aluminum oxide; Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Tapentadol Hydrochloride eq 100mg base extended release tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-Tocopherol (Vitamin E); Hypromellose; Polyethylene Glycol; Polyethylene Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; The Colorant Fd&C Blue 2 Aluminum Lake
|
|||||
Dosage Form | Extended Release Tablet | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [6] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 150mg base extended release tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-Tocopherol (Vitamin E); Hypromellose; Polyethylene Glycol; Polyethylene Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; The Colorant Fd&C Blue 2 Aluminum Lake
|
|||||
Dosage Form | Extended Release Tablet | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [6] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 200mg base extended release tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-Tocopherol (Vitamin E); Hypromellose; Polyethylene Glycol; Polyethylene Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; The Colorant Fd&C Blue 2 Aluminum Lake
|
|||||
Dosage Form | Extended Release Tablet | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [6] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 250mg base extended release tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-Tocopherol (Vitamin E); Hypromellose; Polyethylene Glycol; Polyethylene Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; The Colorant Fd&C Blue 2 Aluminum Lake
|
|||||
Dosage Form | Extended Release Tablet | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [6] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 50mg base solution | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; The Colorant Fd&C Yellow 6 Aluminum Lake; Colorant D&C Yellow 10 Aluminum Lake
|
|||||
Dosage Form | Solution | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 75mg base solution | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; The Colorant Fd&C Yellow 6 Aluminum Lake; Colorant D&C Yellow 10 Aluminum Lake
|
|||||
Dosage Form | Solution | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 50mg base extended release tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-Tocopherol (Vitamin E); Hypromellose; Polyethylene Glycol; Polyethylene Oxide; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; Yellow Iron Oxide
|
|||||
Dosage Form | Extended Release Tablet | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [6] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol Hydrochloride eq 100mg base solution | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; The Colorant Fd&C Yellow 6 Aluminum Lake
|
|||||
Dosage Form | Solution | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Tapentadol 75 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyvinyl alcohol; Povidone; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care; Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Aluminum oxide; Cellulose, microcrystalline; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Depo NF Sub | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [7] | |||
Tapentadol Hydrochloride eq 20mg base/ml solution | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Citric Acid Monohydrate; Purified Water; Raspberry Flavor; Sodium Hydroxide; Sucralose
|
|||||
Dosage Form | Solution | |||||
Company | Collegium Pharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sucralose | DIG Info | Carbonic anhydrase II (Ki = 300 nM) | [8] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.